These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12814443)

  • 1. Variability of heart rate correction methods for the QT interval.
    Desai M; Li L; Desta Z; Malik M; Flockhart D
    Br J Clin Pharmacol; 2003 Jun; 55(6):511-7. PubMed ID: 12814443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
    Malik M
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction.
    Christensen TF; Tarnow L; Randløv J; Kristensen LE; Struijk JJ; Eldrup E; Hejlesen OK
    Diabetologia; 2010 Sep; 53(9):2036-41. PubMed ID: 20496052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
    Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects.
    Davis JD; Hackman F; Layton G; Higgins T; Sudworth D; Weissgerber G
    Br J Clin Pharmacol; 2008 Apr; 65 Suppl 1(Suppl 1):68-75. PubMed ID: 18333868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT analysis: a complex answer to a 'simple' problem.
    Li L; Desai M; Desta Z; Flockhart D
    Stat Med; 2004 Sep; 23(17):2625-43. PubMed ID: 15316947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.
    Zhang L; Chappell J; Gonzales CR; Small D; Knadler MP; Callaghan JT; Francis JL; Desaiah D; Leibowitz M; Ereshefsky L; Hoelscher D; Leese PT; Derby M
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):146-53. PubMed ID: 17414226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The best QT correction formula in a non-hospitalized population: the Fasa PERSIAN cohort study.
    Yazdanpanah MH; Naghizadeh MM; Sayyadipoor S; Farjam M
    BMC Cardiovasc Disord; 2022 Feb; 22(1):52. PubMed ID: 35172723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of QT(c)-prolonging potential of BX471 in healthy volunteers. A 'thorough QT study' following ICH E14 using various QT(c) correction methods.
    Vandemeulebroecke M; Lembcke J; Wiesinger H; Sittner W; Lindemann S
    Br J Clin Pharmacol; 2009 Sep; 68(3):435-46. PubMed ID: 19740402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT interval correction in patients with cirrhosis.
    Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
    J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cut-offs for screening prolonged QT intervals from Fridericia's formula in children and adolescents.
    Hazeki D; Yoshinaga M; Takahashi H; Tanaka Y; Haraguchi Y; Abe M; Koga M; Fukushige T; Nagashima M
    Circ J; 2010 Aug; 74(8):1663-9. PubMed ID: 20534944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
    Khalilieh SG; Yee KL; Fan L; Liu R; Heber W; Dunzo E; Triantafyllou I; Hussaini A; Iwamoto M
    Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of five QT correction formulas using a software-assisted method of continuous QT measurement from 24-hour Holter recordings.
    Molnar J; Weiss J; Zhang F; Rosenthal JE
    Am J Cardiol; 1996 Oct; 78(8):920-6. PubMed ID: 8888666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognostic significance of long QT interval among patients with chest pain: selecting an optimum QT rate correction formula.
    Hasanien AA; Drew BJ; Howie-Esquivel J; Fung G; Harris P
    J Electrocardiol; 2013; 46(4):336-42. PubMed ID: 23597403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the sensitivity of detecting drug-induced QTc changes using subject-specific rate correction.
    Cassani González R; Engels EB; Dubé B; Nadeau R; Vinet A; LeBlanc AR; Sturmer M; Becker G; Kus T; Jacquemet V
    J Electrocardiol; 2012; 45(6):541-5. PubMed ID: 22960165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular haloperidol or lorazepam and QT intervals in schizophrenia.
    Harvey AT; Flockhart D; Gorski JC; Greenblatt DJ; Burke M; Werder S; Preskorn SH
    J Clin Pharmacol; 2004 Oct; 44(10):1173-84. PubMed ID: 15342619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval.
    Malik M; Färbom P; Batchvarov V; Hnatkova K; Camm AJ
    Heart; 2002 Mar; 87(3):220-8. PubMed ID: 11847158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.